Akebia Therapeutics (AKBA) Non-Current Deferred Revenue (2016 - 2026)
Akebia Therapeutics (AKBA) posted Non-Current Deffered Revenue of $43.3 million for Q1 2024, unchanged from $43.3 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Non-Current Deferred Revenue (2016 - 2026) Analysis & Trends
Since Q1 2016, Akebia Therapeutics has reported Non-Current Deffered Revenue for 33 quarters.
- Annual Non-Current Deffered Revenue shows a five-year compound annual growth rate of -4.9% (FY2018 to FY2023).
- In prior years, Akebia Therapeutics' Non-Current Deffered Revenue was $43.3 million in FY2022 (+101.6%), $21.47 million in FY2021 (-15.3%), $25.35 million in FY2020 (-23.5%) and $33.12 million in FY2019 (-40.5%).
- Quarterly Non-Current Deffered Revenue has run from a low of $16.6 million in Q2 2021 to a high of $65.36 million in Q1 2022 over five years.
- On a year-over-year basis, Non-Current Deffered Revenue increased in three of the last eight quarters, with growth averaging 35.4%.
- The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q1 2022, with growth of 238.6%; the weakest was Q1 2021, with a decline of 54.9%.
- According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $43.3 million (Q4 2023), $43.3 million (Q3 2023) and $43.3 million (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Akebia Therapeutics | 149.86 Mn | -512.48 Mn | 30.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 49.56 Mn |
| Jun 30, 2026 | 50.03 Mn |
| Mar 31, 2026 | 50.41 Mn |
| Dec 31, 2025 | 50.61 Mn |
| Sep 30, 2025 | 50.58 Mn |
| Jun 30, 2025 | 51.08 Mn |
| Mar 31, 2025 | 51.55 Mn |
| Mar 31, 2024 | 43.30 Mn |
| Dec 31, 2023 | 43.30 Mn |
| Sep 30, 2023 | 43.30 Mn |
| Jun 30, 2023 | 43.30 Mn |
| Mar 31, 2023 | 43.30 Mn |
| Dec 31, 2022 | 43.30 Mn |
| Sep 30, 2022 | 43.30 Mn |
| Jun 30, 2022 | 43.30 Mn |
| Mar 31, 2022 | 65.36 Mn |
| Dec 31, 2021 | 21.47 Mn |
| Sep 30, 2021 | 27.97 Mn |
| Jun 30, 2021 | 16.60 Mn |
| Mar 31, 2021 | 19.30 Mn |
API Access
Akebia Therapeutics Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();